Abstract: Background: Alteration in the etiology of pediatric bloodstream infections (BSIs) and antimicrobial resistance (AMR) is not well known during the Coronavirus disease 2019 (COVID-19) pandemic. This study aimed to investigate the impact of the COVID-19 pandemic on pediatric BSIs and alteration in antimicrobial resistance phenotypes in Gram-positive bacteria.
Methods: The frequency of BSIs among children under 18 years old was retrospectively recorded in a tertiary children's hospital in Tehran, Iran from February 2020 to December 2022. The status of COVID-19 infection using reverse transcription polymerase chain reaction, bacteremia/fungemia according to BACTEC 9120 Culture System results, characterization of bacteria using biochemical tests, and antimicrobial susceptibility patterns for Gram-positive bacterial isolates using disk diffusion method were determined. Statistical analysis was done to measure the correlation of COVID-19 infection with BSIs and AMR.
Results: Out of 13,345 COVID-19 tests and 4,194 BACTEC blood culture requests, bacteremia/fungemia were confirmed in 10.37% (435/4,194) of the patients who requested both tests simultaneously. The COVID-19 infection was confirmed in 25.3% (110/435) of the patients with bacteremia/fungemia. The infection with characterized Gram-positive bacteria (GPB) and fungi was detected in 32.3% (140/433) and 8.31% (36/433) of the cases, respectively. Coagulase-negative Staphylococcus (CNS, 72, 16.62%), S. aureus (36, 8.3%), and Enterococcus spp. (22, 5%) were among the common isolates. Candida spp. and non-Candida yeasts were detected in 6.7% and 13.4% of the cases, respectively. A positive correlation was shown between the CNS bacteremia and COVID-19 infection (p-value = 0.019). Antibiotic susceptibility testing results showed the highest frequency of resistance to azithromycin among CNS, azithromycin and tetracycline among S. aureus and tetracycline among Enterococcus spp. Methicillin-resistance phenotype in the S. aureus (MRSA) and coagulase-negative Staphylococcus spp. (MR-CNS) was detected in 40% and 61.5% of the strains, respectively and the Enterococci were resistant to vancomycin in 33.3% of the isolates.
Conclusion: A decline in the trend of BSIs by GPB and an increase in AMR was shown in children during the COVID-19 pandemic. Increasing antibiotic resistance is a concern; however, chloramphenicol, linezolid, and vancomycin remain active against common causes of GPB-BSIs.
(© 2024. The Author(s).)
Grant Information: IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; IR.SBMU.MSP.REC.1401.060 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Processing Request
No Comments.